Episode 61: Dr. Stephen Russell and RPE65 Viral Vector Gene Therapy
Dr. Stephen Russell discusses his group's recent publication in Lancet. regarding successful phase 3 trial results of viral vector RPE65 gene therapy, the first such successful trial in medicine.